Maggie is an editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.
She has a BA in English from Penn State University. You can connect with Maggie on LinkedIn.
The UK’s The Food Chain Fights HIV/AIDS Head on With Crisis Support
September 22nd 2021This London-based charity intervenes in the short term when its clients come up against roadblocks that prevent ready access to good levels of nutrition, whether that crisis is nutritional, physical/mental health, housing, or financial related.
Read More
Dr Stefan Anker: Patients With HFpEF Deserve a New Treatment
September 21st 2021With empagliflozin, we now have evidence that another treatment for patients with heart failure with preserved ejection fraction (HFpEF) is possible, said Stefan Anker, MD, PhD, FESC, professor of cardiology, Department of Cardiology, Charité Campus Virchow Clinic, Berlin, Germany, and principal investigator of the EMPEROR-Preserved study.
Read More
States Late to Adopt PrEP Risk Falling Further Behind
September 18th 2021A new analysis of 2014-2018 data among all states plus Washington, DC, for those who have either indications for preexposure prophylaxis (PrEP) or current prescriptions for the preventive treatment, shows a widening gap in PrEP uptake, with states considered early adopters pulling ahead of those considered late adopters.
Read More
Dr Helen Bygrave: Differentiated Service Delivery Can Work Across More Than HIV
September 13th 2021Differentiated service delivery models can be employed to incorporate other chronic disease needs for patients with HIV, emphasized Helen Bygrave, MD, Médecins Sans Frontières (Doctors Without Borders).
Read More
More Focus Needed on Prescribing Disparities for INSTI HIV Treatment
September 10th 2021Data from 2 patient cohorts show that by increasing awareness of such influences as clinic location and patient age and transgender status, gaps in prescription decisions for integrase strand transfer inhibitors (INSTIs) can be lessened.
Read More
Children, Adolescents Considered Obese May Have Greater Risk of NAFLD
September 9th 2021This new study from investigators at Tel Aviv University looked at predictors of nonalcoholic fatty liver disease (NAFLD) among children and adolescents considered obese, because its predictors are not well known in this group.
Read More
Dr Todd Schlesinger on How Medical, Cosmetic, Research Dermatology Interact
September 5th 2021Being a full-service dermatology practice helps make patients' lives easier when they have skin cancer, explained Todd Schlesinger, MD, FAAD, director, Dermatology and Laser Center of Charleston and Clinical Research Center of the Carolinas.
Read More
Dr Rudolf de Boer on SGLT2 Inhibitor Success Across Disease States
September 4th 2021Sodium-glucose co-transporter 2 (SGLT2) inhibitors have been shown to both lower blood pressure and promote weight loss, and they act rather subtly, stated Rudolf de Boer, MD, PhD, clinical cardiologist and professor of translational cardiology, University Medical Center Groningen, the Netherlands.
Read More
STEP Trial Findings Build on SPRINT Results, With a Twist
September 2nd 2021STEP findings build on those from the SPRINT trial, seemingly confirming that intensive treatment for hypertension can reduce the risk of serious adverse cardiovascular (CV) outcomes. However, there was no significant benefit toward risk for all-cause and CV-related mortality.
Read More
Dr Allison Agwu on the Health Effects of In Utero vs Later HIV Acquisition
September 2nd 2021Many young people develop resistance to antiretroviral treatment or they experience lipoatrophy; many also have metabolic complications or inflammation via immune activation, noted Allison Agwu, MD, ScM, FAAP, FIDSA, Johns Hopkins University School of Medicine.
Read More
Outreach, Engagement, Inclusion Infuse the Work of Georgia’s SisterLove Inc
August 30th 2021In 1989, in Atlanta, Georgia, Dázon Dixon Diallo established SisterLove Inc to fill the information and education gap many women, especially Black women, were facing on how the emerging HIV/AIDS epidemic could affect them.
Read More
Dr Børge G. Nordestgaard on Unexplained Omega-3 Mysteries in REDUCE-IT vs STRENGTH
August 29th 2021Both REDUCE-IT and STRENGTH recruited people with very high triglycerides and tested different formulations of omega-3 fatty acids, but the results were different. About 12% of the difference can be explained, noted Børge G. Nordestgaard, MD, DMSc, Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, but 13% cannot be, given that REDUCE-IT had a 25% reduced risk of atherosclerotic cardiovascular disease.
Read More
Dr Rudolf de Boer Discusses Encouraging Trial Results on SGLT2 Use in HFpEF
August 28th 2021Sodium glucose co-transporter 2 (SGLT2) inhibitor use in patients with heart failure with preserved ejection fraction (HFpEF) has generated great enthusiasm, noted Rudolf de Boer, MD, PhD, clinical cardiologist and professor of translational cardiology, University Medical Center Groningen, the Netherlands.
Read More
Dr Stefan Anker: Empagliflozin Improves HFpEF-Related Outcomes Regardless of Diabetes Status
August 27th 2021The composite end point of cardiovascular death and heart failure hospitalization was reduced by 21%, which is highly statistically significant and clinically meaningful, noted Stefan Anker, MD, PhD, FESC, principal investigator of EMPEROR-Preserved.
Read More
Better Screening Efforts Needed for Patients With T2MI, Heart Failure
August 26th 2021Although there is an established link between type 2 myocardial infarction (T2MI) and elevated rates of cardiovascular events, less is known about the connection between T2MI and heart failure—which this new study investigated.
Read More
EMPEROR-Preserved, and the “Very Elegant” SGLT2 Inhibitors, to Highlight ESC Congress
August 25th 2021The lack of approved treatments for heart failure with preserved ejection fraction has represented a significant unmet need for a condition that affects 50% of patients with heart failure, including large subgroups, such as older women.
Read More
Dr Anna Marzec-Bogusławska: At Poland’s National AIDS Center, Our Patients Are Most Important
August 23rd 2021Krajowe Centrum ds AIDS (National AIDS Center) in Warsaw, Poland, was founded in 1993 as part of the country’s Ministry of Health. Its chief area of advocacy and outreach is access to antiretroviral treatment, in addition to new areas of focus that include prevention of sexually transmitted infections and hepatitis C virus.
Read More
Using Ruxolitinib to Target JAK1/2 in T-LBL May Prevent Treatment Resistance
August 21st 2021For pediatric patients with T-cell origin lymphoblastic leukemia (T-LBL) with disease progression following second-line treatment, investigators found that the JAK1/2 pathway may be a new actionable target through treatment with ruxolitinib.
Read More
Dr Todd Schlesinger: Morphology, Immunosuppression Affect Actinic Keratosis Outcomes
August 19th 2021Actinic keratosis outcomes can be affected by several variables, and these lesions need to be treated to minimize progression risk, noted Todd Schlesinger, MD, FAAD, director, Dermatology and Laser Center of Charleston and Clinical Research Center of the Carolinas.
Read More
From a Humble Start, Romania’s ARAS Expands Beyond the HIV Space
August 18th 2021Asociaţia Română Anti-SIDA (ARAS; Romanian Association Against AIDS) was founded on April 10, 1992, just 3 years after the fall of communism, making it the first such organization in the country following a time when HIV was not officially acknowledged nor prevention of HIV and sexually transmitted infections discussed.
Read More
HIV Thriver, Advocate Dawn Averitt on Overcoming HIV-Related Health Care Disparities
August 9th 2021Dawn Averitt opened the session, “Refocus on HIV: How Innovation in HIV Will Address Individual Patient Needs,” on day 1 of IAS 2021, this year's virtual annual meeting of the International AIDS Society, which took place July 18-21.
Read More